-
Norwich Expands Capabilities For Phase I-III Clinical Trials
2/3/2012
Norwich Clinical Services (NCS), a global provider of clinical research services for the pharmaceutical and biotech industries, recently announced a significant expansion to its clinical research capabilities in order to meet growing market demand.
-
NextPharma Technologies Hosts Inauguration Ceremony To Mark Official Opening Of Its ‘State Of The Art’ Cold Chain And Logistics Warehouse In Werne, Germany
2/3/2012
NextPharma, the leading European provider of product development, contract manufacturing and cold chain and logistics outsourcing services to the pharmaceutical
and biotechnology industries, is pleased to announce the official opening of its "state of the art" Cold Chain and Logistics (CLS) warehouse in Werne, Germany at an inauguration ceremony attended by local dignitaries and many of NextPharma's customers.
-
OctoPlus Enters Into Drug Development And Manufacturing Contract With Ferring Pharmaceuticals A/S
2/3/2012
OctoPlus N.V. ("OctoPlus" or the "Company") (Euronext: OCTO), announces today that a formulation development and manufacturing contract has been signed with Ferring Pharmaceuticals A/S, a leading innovative pharmaceutical company.
-
UBM Canon Pharmaceutical Group Announces Realignment For Future Growth
2/1/2012
UBM Canon, the global authority for the advanced manufacturing and medical device industries, announced today a reorganization between the Pharmaceutical Media Group and Data Products teams to provide an integrated, holistic media solution for clients and audience alike.
-
Biostar Pharmaceuticals Selected By The FMMU To Cooperate In The Fields Of Research And Product Development
2/1/2012
Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a developer, manufacturer and marketer of pharmaceutical and health supplement products for a variety of diseases and conditions, today announced that on January 8th it was one of nine PRC pharmaceutical companies selected to cooperate with The Fourth Military Medical University ("FMMU") (website: http://en.fmmu.edu.cn) in the fields of research and product development.
-
Encap Drug Delivery Adds New Commercial Product To Portfolio
2/1/2012
Encap Drug Delivery, the world's leading contract development and manufacturing organization (CDMO) totally dedicated to liquid and semi-solid (hot melt) filled capsules, announces the addition of a further pharmaceutical product to its portfolio of commercial products.
-
Alkermes Initiates Open-Label Pilot Study Of VIVITROL To Evaluate Impact On Re-Arrest And Re-Incarceration In Offenders With History Of Opioid Dependence
1/31/2012
Alkermes plc recently announced the initiation of a pilot study of VIVITROL (naltrexone for extended-release injectable suspension) in prisoners with a pre-incarceration history of opioid dependence.
-
Aptar Pharma Expands Presence In India With A New Manufacturing Site Near Mumbai
1/25/2012
Aptar Pharma, world leader in the development and manufacturing of nasal and pulmonary drug delivery devices, recently announces the opening of a new facility near Mumbai, India.
-
Patheon Adds Soft Gel Capsule Capabilities Through New Partnership With Procaps, S.A.
1/20/2012
Patheon and PROCAPS S.A. are pleased to announce an agreement to provide the pharmaceutical industry a new world-class line of prescription pharmaceutical soft-gel product development and manufacturing services.
-
APR Applied Pharma Research s.a., Labtec GmbH And Norgine BV Announce The Signature Of An Exclusive Licensing Agreement Under Which Norgine Will Market And Distribute Setofilm
1/18/2012
APR Applied Pharma Research s.a. ("APR"), Labtec GmbH ("Labtec") and Norgine BV ("Norgine") announce the signature of an exclusive licensing agreement under which Norgine will market and distribute Setofilm Ondansetron Oral Dispersible Film ("ODF"), in Europe and selected non-European countries.
